Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: Clinical Study on Wuling Powder in Treating Metabolic Syndrome of Spleen Deficiency and Dampness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Wuling Powder for metabolic syndrome of spleen deficiency and dampness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wuling Powder

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Metabolic Syndrome | Phase 4 | Status: UNKNOWN